MOTE Therapeutics
PrivateLast Round
Series A
Jul 3, 2025
Company Overview
MOTE Therapeutics is a biotechnology company developing a next-generation RNA delivery platform to transport RNA payloads to cells and tissues outside the liver.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MOTE Therapeutics Comparables
Compare MOTE Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Starna Therapeutics | 86% | |
| NanoVation Therapeutics | 85% | |
| Liberate Bio | 83% | |
MOTE Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 3, 2025 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 3, 2025
$40M round completed.
MOTE Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MOTE Therapeutics's valuation, stock price, and market status.